Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?

Hatzipanagiotou ME, Pigerl M, Gerken M, Räpple S, Zeltner V, Hetterich M, Ugocsai P, Fernandez-Pacheco M, Inwald EC, Klinkhammer-Schalke M, Ortmann O, Seitz S

Open source

DOI: 10.1007/s00432-023-05060-y
Published: 2023 Oct
Container: Journal of cancer research and clinical oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00432-023-05060-y,
  title = {Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?},
  author = {Hatzipanagiotou ME and Pigerl M and Gerken M and Räpple S and Zeltner V and Hetterich M and Ugocsai P and Fernandez-Pacheco M and Inwald EC and Klinkhammer-Schalke M and Ortmann O and Seitz S},
  year = {2023},
  journal = {Journal of cancer research and clinical oncology},
  doi = {10.1007/s00432-023-05060-y},
  url = {https://doi.org/10.1007/s00432-023-05060-y}
}

RIS

TY  - JOUR
TI  - Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?
AU  - Hatzipanagiotou ME
AU  - Pigerl M
AU  - Gerken M
AU  - Räpple S
AU  - Zeltner V
AU  - Hetterich M
AU  - Ugocsai P
AU  - Fernandez-Pacheco M
AU  - Inwald EC
AU  - Klinkhammer-Schalke M
AU  - Ortmann O
AU  - Seitz S
PY  - 2023
JO  - Journal of cancer research and clinical oncology
DO  - 10.1007/s00432-023-05060-y
UR  - https://doi.org/10.1007/s00432-023-05060-y
ER  -

APA

ME, H., M, P., M, G., S, R., V, Z., M, H., P, U., M, F., EC, I., M, K., O, O., & S, S. (2023). Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?. Journal of cancer research and clinical oncology. https://doi.org/10.1007/s00432-023-05060-y

Source records

pubmed · retrieved 2026-09-27T00:20:49.573Z